Aspira Womens Health Inc. buy krebskrebs
Start price
24.01.22
/
50%
€14.78
Target price
24.01.23
€24.00
Performance (%)
-57.36%
End price
25.01.23
€6.30
Summary
This prediction ended on 25.01.23 with a price of €6.30. Massive losses of -57.36% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aspira Womens Health Inc. | - | - | - | - |
| iShares Core DAX® | 0,75 % | -8,50 % | 2,57 % | 44,61 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % | 15,68 % | 70,74 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % | 29,65 % | 48,21 % |
| iShares S&P 500 | -0,59 % | -2,87 % | 9,96 % | 54,25 % |
Comments by krebskrebs for this prediction
In the thread Vermillion Inc. diskutieren
In the thread Trading Vermillion Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten